| Literature DB >> 35708383 |
Shuiping Yu1, Guandou Yuan1, Shiliu Lu1, Jiangfa Li2, Bo Tang1, Fudi Zhong1, Huizhao Su1, Songqin He1.
Abstract
Background: Repeat laparoscopic liver resection has been used safely and effectively on hepatocellular carcinoma (HCC). However, few studies have been performed on repeat HCC surgery by a da Vinci robot. This study aims to evaluate the outcomes of the patients with repeat HCC treated using a da Vinci robot or laparoscopic system at a single centre.Entities:
Keywords: Da Vinci robot; hepatocellular carcinoma; laparoscopic; repeat surgery
Year: 2022 PMID: 35708383 PMCID: PMC9306131 DOI: 10.4103/jmas.JMAS_111_21
Source DB: PubMed Journal: J Minim Access Surg ISSN: 1998-3921 Impact factor: 1.018
Information of patient of robot assisted on recurrent hepatocellular carcinoma
| Case | Gender | Age (years) | The operative time (min) | The blood loss (ml) | Hospital time (days) | Turned to open surgery | Serious complication |
|---|---|---|---|---|---|---|---|
| 1 | Female | 65 | 160 | 300 | 12 | N | N |
| 2 | Male | 45 | 150 | 380 | 9 | N | N |
| 3 | Female | 61 | 180 | 320 | 11 | N | N |
| 4 | Male | 55 | 130 | 100 | 7 | N | N |
| 5 | Female | 60 | 130 | 180 | 5 | N | N |
| 6 | Female | 64 | 120 | 350 | 9 | N | N |
| 7 | Female | 58 | 160 | 250 | 9 | N | N |
| 8 | Male | 38 | 190 | 360 | 11 | N | N |
| 9 | Female | 68 | 180 | 300 | 10 | N | N |
| 10 | Female | 70 | 150 | 380 | 12 | Y | N |
| 11 | Male | 47 | 120 | 180 | 7 | N | N |
Information of patients of laparoscopic repeat liver resection for recurrent hepatocellular carcinoma
| Case | Gender | Age (years) | The operative time (min) | The blood loss (ml) | Hospital time (days) | Turned to open surgery | Serious operation complication |
|---|---|---|---|---|---|---|---|
| 1 | Male | 47 | 130 | 180 | 7 | N | N |
| 2 | Female | 42 | 110 | 280 | 8 | N | N |
| 3 | Male | 41 | 180 | 300 | 12 | Y | N |
| 4 | Male | 56 | 120 | 120 | 6 | N | N |
| 5 | Male | 65 | 110 | 150 | 6 | N | N |
| 6 | Female | 64 | 180 | 350 | 10 | N | N |
| 7 | Female | 57 | 120 | 200 | 9 | N | N |
| 8 | Male | 28 | 190 | 360 | 12 | Y | N |
| 9 | Male | 68 | 200 | 360 | 13 | Y | N |
| 10 | Female | 72 | 160 | 350 | 12 | N | N |
| 11 | Male | 45 | 120 | 300 | 10 | N | N |
| 12 | Male | 53 | 110 | 160 | 7 | N | N |
| 13 | Female | 60 | 120 | 150 | 6 | N | N |
Figure 1Port placement in the supine and position of head higher and foot lower
Figure 2Port placement in the supine and position of head higher and foot lower (after docking)
Figure 3Separation of abdominal wall adhesion in recurrent hepatocellular carcinoma by da Vinci robot
Figure 4Tumour incision in recurrent hepatocellular carcinoma surgery by da Vinci robot
Figure 5Separation of abdominal wall adhesion in recurrent hepatocellular carcinoma surgery by laparoscopic system
Figure 6Tumour incision in recurrent hepatocellular carcinoma surgery by laparoscopic system
Figure 7Scar in the first open surgery vs in the repeat surgery of da Vinci robot of hepatocellular carcinoma
Comparison of patient with robot-assisted and laparoscopic system on recurrent hepatocellular carcinoma (X̄±S)
| Group | The operative time (min) | The blood loss (ml) | Hospital time (days) | Turned to open surgery rate (%) | Serious complication |
|---|---|---|---|---|---|
| A | 152±25 | 284±89 | 9±2 | 9 | 0 |
| B | 142±34 | 251±92 | 9±3 | 23 | 0 |
| T | 0.45 | 0.39 | 0.92 | ||
|
| 8.19 | ||||
|
| >0.05 | >0.05 | >0.05 | <0.05 |
A: Robot-assisted groups, B: Laparoscopic groups